Clinical Trial Update: Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating rituximab in combination with GM-CSF in patients with follicular B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• sargramostim (sargramostim)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED